Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy. (41/311)

 (+info)

Outcome following resection for patients with primary mediastinal nonseminomatous germ-cell tumors and rising serum tumor markers post-chemotherapy. (42/311)

 (+info)

Selegiline and oxidative stress in HIV-associated cognitive impairment. (43/311)

 (+info)

In vivo pharmaco-proteomic analysis of hydroxyurea induced changes in the sickle red blood cell membrane proteome. (44/311)

 (+info)

Warfarin sensitivity genotyping: a review of the literature and summary of patient experience. (45/311)

 (+info)

Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. (46/311)

 (+info)

Utility and relationships of biomarkers of smoking in African-American light smokers. (47/311)

 (+info)

Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response. (48/311)

 (+info)